Faculty, Staff and Student Publications
Publication Date
4-10-2025
Journal
Nucleic Acids Research
DOI
10.1093/nar/gkaf302
PMID
40226918
PMCID
PMC11995263
PubMedCentral® Posted Date
4-14-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Two-cell-like cells (2CLCs), a rare population (∼0.5%) in mouse embryonic stem cell (mESC) cultures, are in a transient totipotent-like state resembling that of 2C-stage embryos, and their discovery and characterization have greatly facilitated the study of early developmental events, such as zygotic genome activation. However, the molecular determinants governing 2C-like reprogramming remain to be elucidated. Here, we show that ZBTB24, CDCA7, and HELLS, components of a molecular pathway that is involved in the pathogenesis of immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome, function as negative regulators of 2C-like reprogramming by maintaining DNA methylation of the Dux cluster, a master inducer of the 2C-like state. Disruption of the ZBTB24-CDCA7-HELLS axis results in Dux hypomethylation and derepression, leading to dramatic upregulation of 2C-specific genes, which can be reversed by site-specific re-methylation in the Dux promoter. We also provide evidence that CDCA7 is enriched at the Dux cluster and recruits the CDCA7-HELLS chromatin remodeling complex to constitutive heterochromatin. Our study uncovers a key role for the ZBTB24-CDCA7-HELLS axis in safeguarding the mESC state by suppressing the 2C-like reprogramming.
Keywords
Animals, Mice, Cellular Reprogramming, Homeodomain Proteins, DNA Methylation, DNA Helicases, Mouse Embryonic Stem Cells, Promoter Regions, Genetic, Nuclear Proteins, Repressor Proteins
Published Open-Access
yes
Recommended Citation
Guo, Dan; Du, Zeling; Liu, Youqi; et al., "The ZBTB24-CDCA7-HELLS Axis Suppresses the Totipotent 2C-Like Reprogramming by Maintaining Dux Methylation and Repression" (2025). Faculty, Staff and Student Publications. 4291.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4291
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons